These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36709789)

  • 1. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance.
    Yang Z; Ma R; Li J; Zhao L
    Pharmacol Res; 2023 Feb; 188():106678. PubMed ID: 36709789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma.
    Sugihara H; Ishimoto T; Miyake K; Izumi D; Baba Y; Yoshida N; Watanabe M; Baba H
    Int J Mol Sci; 2015 Nov; 16(11):27824-34. PubMed ID: 26610479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting non-coding RNAs to overcome cancer therapy resistance.
    Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
    Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.
    Feng Q; Zhang H; Yao D; Chen WD; Wang YD
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs).
    Dashtaki ME; Ghasemi S
    Curr Mol Pharmacol; 2023; 16(8):855-869. PubMed ID: 36475334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
    Lin Z; Xie X; Lu S; Liu T
    Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of noncoding RNAs in septic acute kidney injury.
    Yue L; Gu Y; Xu J; Liu T
    Biomed Pharmacother; 2023 Sep; 165():115269. PubMed ID: 37541179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
    Lin Z; Lu S; Xie X; Yi X; Huang H
    Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
    Wei L; Sun J; Zhang N; Shen Y; Wang T; Li Z; Yang M
    Front Cell Dev Biol; 2021; 9():764313. PubMed ID: 34881242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity.
    Mahabady MK; Mirzaei S; Saebfar H; Gholami MH; Zabolian A; Hushmandi K; Hashemi F; Tajik F; Hashemi M; Kumar AP; Aref AR; Zarrabi A; Khan H; Hamblin MR; Nuri Ertas Y; Samarghandian S
    J Cell Physiol; 2022 May; 237(5):2309-2344. PubMed ID: 35437787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
    Fang Y; Zhang X; Huang H; Zeng Z
    J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
    Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
    Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNAs as Novel Biomarkers in Cancer Drug Resistance.
    Yang H; Qi C; Li B; Cheng L
    Curr Med Chem; 2022; 29(5):837-848. PubMed ID: 34348605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways.
    Hashemi M; Roshanzamir SM; Paskeh MDA; Karimian SS; Mahdavi MS; Kheirabad SK; Naeemi S; Taheriazam A; Salimimoghaddam S; Entezari M; Mirzaei S; Samarghandian S
    Eur J Pharmacol; 2023 Feb; 941():175380. PubMed ID: 36627099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs.
    Sarfraz M; Abida ; Eltaib L; Asdaq SMB; Guetat A; Alzahrani AK; Alanazi SS; Aaghaz S; Singla N; Imran M
    Pathol Res Pract; 2024 Mar; 255():155179. PubMed ID: 38320439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs in Muscle Atrophy.
    Li Y; Meng X; Li G; Zhou Q; Xiao J
    Adv Exp Med Biol; 2018; 1088():249-266. PubMed ID: 30390255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.